KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vir Biotechnology (VIR) Deferred Taxes (2018 - 2024)

Historic Deferred Taxes for Vir Biotechnology (VIR) over the last 3 years, with Q4 2024 value amounting to -$2.6 million.

  • Vir Biotechnology's Deferred Taxes fell 14863.59% to -$2.6 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$3.6 million, marking a year-over-year change of. This contributed to the annual value of -$2.9 million for FY2024, which is 17742.24% down from last year.
  • Latest data reveals that Vir Biotechnology reported Deferred Taxes of -$2.6 million as of Q4 2024, which was down 14863.59% from $57000.0 recorded in Q3 2024.
  • Vir Biotechnology's Deferred Taxes' 5-year high stood at $57000.0 during Q3 2024, with a 5-year trough of -$2.6 million in Q4 2024.